History
  • No items yet
midpage
545 F.Supp.3d 120
S.D.N.Y.
2021
Read the full case

Background:

  • Lead Plaintiff Sjunde AP-Fonden (AP7) sued Goldman Sachs, CEO Lloyd Blankfein, President/COO Gary Cohn, and President/COO Harvey Schwartz under §10(b), Rule 10b-5 and §20(a) arising from Goldman’s role underwriting three 1MDB bond offerings (2012–2013) that raised $6.5 billion and yielded ~$600 million in fees.
  • Goldman employees (not defendants) repeatedly flagged Jho Low and 1MDB as suspicious; Goldman’s Compliance and Legal groups twice rejected Low for private wealth accounts, yet Goldman underwrote three deals (Projects Magnolia, Maximus, Catalyze) with numerous red flags (astronomical fees, no-bid/private placements, IPIC guarantees, vague use of proceeds).
  • After criminal investigations and guilty pleas by Goldman personnel (notably Leissner), Plaintiff alleged that post-scandal public statements and omissions by Goldman and senior officers were false or misleading during the class period (Feb 28, 2014–Dec 20, 2018).
  • Defendants moved to dismiss the Second Amended Complaint; the court applied Rule 12(b)(6) and the PSLRA heightened pleading standards on falsity, scienter, and loss causation.
  • The Court dismissed all claims against Schwartz for failure to plead scienter, but denied dismissal as to Blankfein, Cohn, and Goldman; it also declined to take judicial notice of factual admissions in the DOJ Deferred Prosecution Agreement (DPA), taking notice only of the DPA filing.

Issues:

Issue Plaintiff's Argument Defendant's Argument Held
Falsity of public statements (controls, fees, Low/1MDB role, Coastal Energy) Statements and omissions misrepresented Goldman’s controls, knowledge of Low’s involvement, that fees reflected underwriting risk, and that no third-party payments were made Many statements were puffery or literally accurate; financial statements and SOX certifications were truthful; some statements concerned known public facts Court: risk-management puffery and certain financial/SOX statements not actionable; several statements/omissions (no evidence of Low’s involvement, denial of third-party payments, claims of no visibility into diversion, statements about fees reflecting risk, Coastal Energy omissions) pleaded with sufficient falsity to survive dismissal
Scienter (Blankfein, Cohn, Schwartz, Goldman) High-level executives approved all three deals, met with Low, ignored internal red flags and warnings (e.g., sidelining of Ryan), benefitted from fees—supporting recklessness/conscious misbehavior Transaction approvals and business judgment do not alone show fraud; stock repurchases negate motive; Schwartz had no involvement in the deals Court: scienter adequately pled for Blankfein and Cohn (imputes to Goldman); scienter not pled for Schwartz—claims against him dismissed
Loss causation (stock drops after Nov–Dec 2018 disclosures) Six disclosures in Nov–Dec 2018 partially and/or fully corrected prior misstatements and caused stock declines tied to revelation of concealed facts Disclosures were incremental or repeated known risks already public; many were non-corrective or merely materialization of known risk Court: some disclosures (notably the previously undisclosed Blankfein–Low meeting) plausibly corrective; others less so, but loss causation cannot be dismissed at pleading stage—fact issues for trial
Section 20(a) control-person liability Blankfein and Cohn exercised control and were culpable participants in the alleged primary violations No primary violation adequately pled as to Schwartz or insufficient control participation Court: §20(a) claims allowed against Blankfein and Cohn; §20(a) claim dismissed as to Schwartz due to lack of primary violation

Key Cases Cited

  • Ashcroft v. Iqbal, 556 U.S. 662 (pleading must be plausible, not conclusory)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility standard for complaints)
  • Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (PSLRA scienter: strong inference must be cogent and at least as compelling as nonfraudulent inference)
  • ECA & Local 134 IBEW Joint Pension Tr. of Chi. v. J.P. Morgan Chase Co., 553 F.3d 187 (statements of general business principles often non-actionable puffery)
  • Novak v. Kasaks, 216 F.3d 300 (PSLRA/Rule 9(b) standards; confidential sources and scienter pleading)
  • Rombach v. Chang, 355 F.3d 164 (Rule 9(b) requires specific pleading of misleading statements and why they were misleading)
  • Dura Pharms., Inc. v. Broudo, 544 U.S. 336 (loss causation requires causal connection between fraud and loss)
  • In re Morgan Stanley Info. Fund Sec. Litig., 592 F.3d 347 (contextual truthfulness and examination of statements taken together)
Read the full case

Case Details

Case Name: Plaut v. The Goldman Sachs Group, Inc.
Court Name: District Court, S.D. New York
Date Published: Jun 28, 2021
Citations: 545 F.Supp.3d 120; 1:18-cv-12084
Docket Number: 1:18-cv-12084
Court Abbreviation: S.D.N.Y.
Log In
    Plaut v. The Goldman Sachs Group, Inc., 545 F.Supp.3d 120